Regeneron Pharmaceuticals (NASDAQ: REGN)
Regeneron Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Regeneron Pharmaceuticals Company Info
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
News & Analysis
Biotech vs Pharma: What's the Difference?
Investing in Gene-Editing Stocks
1 Dividend Stock Down 30% to Buy and Hold for the Next Decade
Investing in Biotech Stocks in 2025
This Company Just Initiated a Quarterly Dividend: Time to Buy?
Why Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street
The Best CRISPR Companies to Invest In
These CRISPR stocks could be big winners for patient investors.
Valuation
Podcast Episodes
Regeneron Stock Rose on COVID-19 Breakthrough
Regeneron Pharmaceuticals stock got a shot in the arm after it announced a possible drug candidate for coronavirus.
3 Top Stocks After #ASH18
Positive trial data unveiled at the American Society of Hematology conference makes these top stocks to watch in 2019.
Is Regeneron Pharmaceuticals the Best Biotech Stock to Buy?
With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players.
Earnings Transcripts
Regeneron Pharmaceuticals Inc (REGN) Q3 2021 Earnings Call Transcript
REGN earnings call for the period ending September 30, 2021.
Regeneron Pharmaceuticals Inc (REGN) Q2 2021 Earnings Call Transcript
REGN earnings call for the period ending June 30, 2021.
Regeneron Pharmaceuticals Inc (REGN) Q1 2021 Earnings Call Transcript
REGN earnings call for the period ending March 31, 2021.
Regeneron Pharmaceuticals Inc (REGN) Q4 2020 Earnings Call Transcript
REGN earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.